Patents by Inventor Simon Christopher Cranko LUCAS

Simon Christopher Cranko LUCAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,3-dihydrobenzohurans as bromodomain inhibitors
    Patent number: 11319307
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: May 3, 2022
    Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Simon Christopher Cranko Lucas, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • Benzofuran derivatives and their use as bromodomain inhibitors
    Patent number: 11273146
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: March 15, 2022
    Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Simon Christopher Cranko Lucas, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • Pyrazole derivatives as bromodomain inhibitors
    Patent number: 10966961
    Abstract: The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: April 6, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Gemma Michele Liwicki, Simon Christopher Cranko Lucas, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson
  • 2,3-DIHYDROBENZOFURANS AS BROMODOMAIN INHIBITORS
    Publication number: 20200291009
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: October 4, 2018
    Publication date: September 17, 2020
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Simon Christopher Cranko LUCAS, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN
  • BENZOFURAN DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
    Publication number: 20200289464
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: October 4, 2018
    Publication date: September 17, 2020
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Simon Christopher Cranko LUCAS, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN
  • PYRAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
    Publication number: 20190381010
    Abstract: The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.
    Type: Application
    Filed: February 27, 2018
    Publication date: December 19, 2019
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Gemma Michele LIWICKI, Simon Christopher Cranko LUCAS, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON